Tarsons Products (TARSONS) — Financial Results

📢 Key Event
Tarsons reports 21% YoY consolidated revenue growth to ₹110.2 crore in Q1 FY27, PAT turns negative.

🔄 What Changed
PAT shifted from ₹1.8 crore positive to -₹1.4 crore negative; Cash PAT rose 18% to ₹25.6 crore; Gross margin fell to 64.9% from 67.9%; Revenue growth held at 21% YoY across consolidated and standalone.

🔮 What's Next
Revenue from new Panchla and Amta facilities expected to flow from FY28 and FY29; Export growth to target 120 countries in 5-10 years; Continued investment in cell culture and automation to drive margin recovery.

💡 Investor Takeaway
The company is investing heavily in new capacity, causing short-term losses but positioning for long-term export and product growth with strong cash flow.

Tarsons Products Limited reported consolidated revenue of ₹110.2 crores for Q1 FY27, up 21% YoY, driven by domestic and export growth, though PAT turned negative at ₹1.4 crores due to accelerated depreciation and new facility costs. Gross margin declined to 64.9% from 67.9% as raw material prices rose and new plant investments ramped up. Cash PAT rose 18% YoY to ₹25.6 crores, reflecting strong cash conversion despite headline losses. The company highlighted ongoing commissioning of new facilities in Panchla and Amta, with revenue expected to flow from FY28 onward, and reaffirmed long-term growth ambitions in labware exports and product diversification.

📄 View Original Announcement (PDF)

📊 Stock Analysis — TARSONS ✨ Ask AI About This

About Tarsons Products Limited (TARSONS)

Healthcare · Healthcare Equipment & Supplies · Listed on NSE

Market Cap: ₹1,101.1 Cr P/E: 36.9

View full TARSONS stock details →

📡 Get AI alerts when TARSONS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track TARSONS — Free

💡 Ask AI about this filing

"How will PAT turn positive again?" "What is the revenue contribution timeline for Panchla?" "How does export growth target 120 countries?"

Ask AI Free →

📊 More TARSONS filings

See all TARSONS filings →

🔥 Also filed on 11 August 2026

ULTRACEMCO UltraTech Cement Limited Announcement SUDEEPPHRM Sudeep Pharma Limited Financial Results SUTLEJTEX Sutlej Textiles and Industries Limited Financial Results RBZJEWEL RBZ Jewellers Limited Financial Results TATVA Tatva Chintan Pharma Chem Limited Corporate Action AETHER Aether Industries Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when TARSONS files new disclosures

Track TARSONS filings, board meetings, and corporate actions. Free email alerts at 5 PM.